Skip to main content

Addressing Antimicrobial Resistance for better cancer care outcomes

About UICC's self-guided coursesFor UICC members only badge

  • This course was originally designed as a Master course. It was delivered from September to December 2021.
  • It is now open to all UICC members registered on the eLearning platform.
  • You may complete all items in this course or complete only the items that are of interest to you. If you complete all course items you will receive a certificate of completion.
  • This course is accredited by the Accreditation Council of Oncology in Europe (ACOE) and its completion gives 7 European CME Credits.
  • This course is self-paced. The required time to complete this course is approximately 7 hours.
  • To access the course you must sign in to the eLearning platform. If you are not registered and work for a UICC member organisation, you can sign up here.
Overview of this course
Antimicrobial resistance (AMR) is a growing public health issue that needs urgent attention around the world. Infections become drug-resistant when bacteria adapts, developing the ability to resist the drugs designed to kill them. The result is that many antibiotics are becoming less effective at treating illnesses, and without effective antibiotics, routine surgery and lifesaving treatments like chemotherapy, can become life-threatening.

The purpose of this course is to increase awareness on AMR among cancer professionals, broaden the knowledge of the cancer community on the importance of addressing this issue as an integral part of cancer care and promote best practices addressing AMR globally.

Learning objectives
After completion of the course participants will be able to:
  1. Describe what antimicrobial resistance is and how it has become a public health issue.
  2. Understand how antimicrobial resistance negatively impacts cancer care outcomes globally and in their own setting.
  3. Explain the approaches used to tackle the global threat of antimicrobial resistance and potential solutions to address this threat.
  4. Learn about national action plans for antimicrobial resistance (NAPs) and understand the importance of their implementation.
  5. Gain an insight into the role of access to medicines and infectious disease diagnostics in addressing AMR.
Target audience
The course is designed for cancer advocates, oncology professionals, the private sector and other stakeholders working in the field of cancer